Abbott Laboratories
ABT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11 | $11 | $10 | $11 |
| % Growth | 2% | 7.6% | -5.6% | – |
| Cost of Goods Sold | $5 | $5 | $5 | $5 |
| Gross Profit | $6 | $6 | $5 | $6 |
| % Margin | 55.7% | 56.4% | 52.6% | 51% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $4 | $4 | $4 |
| Operating Income | $2 | $2 | $2 | $2 |
| % Margin | 17.9% | 18.4% | 16.3% | 18.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $2 | $2 | $2 | $2 |
| Tax Expense | $1 | $0 | $0 | -$7 |
| Net Income | $2 | $2 | $1 | $9 |
| % Margin | 14.5% | 16% | 12.8% | 84.1% |
| EPS | 0.94 | 1.02 | 0.758 | 5.33 |
| % Growth | -7.8% | 34.5% | -85.8% | – |
| EPS Diluted | 0.94 | 1.01 | 0.758 | 5.27 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $3 | $3 | $3 | $3 |
| % Margin | 26.5% | 27.4% | 25.8% | 27.2% |